4SC AG
Prelisting capital increase successfully completed by arthritis drug developer
Published in Lab Business Week, January 8th, 2006
On the occasion of a private placement, institutional investors as well as existing investors subscribed 2,396,438 shares at the price of EUR4.24 per share. The company's share capital thus increases by 2,396,438 to 10,530,077 shares. The additional capital is to be used chiefly for clinical studies and for further extension of the product pipeline.
On November 25, 4SC AG has filed for listing under the regulated market at the Frankfurt Stock Exchange together with admission to the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-01-08)
More Articles from Lab Business Week
- Aksys, Ltd.
Dialysis systems maker implements more focused strategy to reduce cash burn rate - Alexion Pharmaceuticals, Inc.
Hematologic-focused pharmaceutical firm posts loss of $1.16 per share - Allion Healthcare, Inc.
Allion Healthcare files registration statement for public offering of common stock - AnorMED, Inc.
Hematology-focused biotech firm exercises underwriters' option - Antisense Pharma
Cancer drug developer raises $18M in venture financing - Applied Biosystems Group
Equity investment in VisiGen Biotechnologies completed - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
